Statins linked to lower dementia risk in type 2 diabetes patients

A large-scale Danish study suggests that initiating statin treatment shortly after a type 2 diabetes diagnosis may reduce the risk of developing dementia by 15%. The research, presented at the European Society of Cardiology Congress and published in The Lancet Regional Health – Europe, analyzed data from 132,585 individuals between 2006 and 2021.

Researchers found that patients who began statin therapy within one year of their diabetes diagnosis saw a 15% lower risk of dementia compared to those who did not initiate statins. Those who started treatment later, between one and five years after diagnosis, saw a 10% reduction in risk. The study highlights the importance of managing low-density lipoprotein cholesterol (LDL-C) in diabetic patients to mitigate cognitive decline.

Given that dementia cases are projected to rise significantly with aging populations, experts noted that the widespread availability and low cost of statins make these findings potentially impactful for preventative healthcare.